Approach-based Comparative and Predictor Analysis of 30-day Readmission, Reoperation, and Morbidity in Patients Undergoing Lumbar Interbody Fusion Using the ACS-NSQIP Dataset. Issue 6 (15th March 2019)

• Record Type: Journal Article
• Authors: Katz, Austen David; Mancini, Nickolas; Karukonda, Teja; Greenwood, Matthew; Cote, Mark; Moss, Isaac L.
• Is Part Of: Spine. Volume 44:Issue 6(2019)
• Publication Date: 2019-03-15
• Subjects: ACS-NSQIP -- anterior lumbar interbody fusion -- database -- lateral lumbar interbody fusion -- lumbar interbody fusion -- morbidity -- outcomes -- posterior lumbar interbody fusion -- posterolateral fusion -- readmission -- reoperation -- transforaminal lumbar interbody fusion; Spine -- Abnormalities -- Periodicals; Spine -- Diseases -- Periodicals; Spine -- Surgery -- Periodicals; 616.73005
• DOI: 10.1097/BRS.0000000000002850
• Languages: English
• ISSNs: 0362-2436

Abstract

Abstract : Study Design: A retrospective cohort study. Objective: The aim of this study was to determine the difference in 30-day readmission, reoperation, and morbidity for patients undergoing either posterior or anterior lumbar interbody fusion. Summary of Background Data: Despite increasing utilization of lumbar interbody fusion to treat spinal pathology, few studies compare outcomes by surgical approach, particularly using large nationally represented cohorts. Methods: Patients who underwent lumbar interbody fusion were identified using the NSQIP database. Rates of readmission, reoperation, morbidity, and associated predictors were compared between posterior/transforaminal (PLIF/TLIF) and anterior/lateral (ALIF/LLIF) lumbar interbody fusion using multivariate regression. Bonferroni-adjusted alpha-levels were utilized whereby variables were significant if their P values were less than the alpha-level or trending if their P values were between 0.05 and the alpha-level. Results: We identified 26, 336 patients. PLIF/TLIF had greater operative time ( P = 0.015), transfusion ( P < 0.001), UTI ( P = 0.008), and stroke/CVA ( P = 0.026), but lower prolonged ventilation ( P < 0.001) and DVT ( P = 0.002) rates than ALIF/LLIF. PLIF/TLIF independently predicted greater morbidity on multivariate analysis (odds ratio: 1.155, P = 0.0019). In both groups, experiencing a complication and, in PLIF/TLIF, ASA-class ≥3 predicted readmission ( P < 0.001). Increased age trended toward readmission in ALIF/LLIF ( P = 0.003); increased white cell count ( P = 0.003), dyspnea ( P = 0.030), and COPD ( P = 0.005) trended in PLIF/TLIF. In both groups, increased hospital stay and wound/site-related complication predicted reoperation ( P < 0.001). Adjunctive posterolateral fusion predicted reduced reoperation in ALIF/LLIF ( P = 0.0018). ASA-class ≥3 ( P = 0.016) and age ( P = 0.021) trended toward reoperation in PLIF/TLIF and ALIF/LLIF, respectively. In both groups, age, hospital stay, reduced hematocrit, dyspnea, ASA-class ≥3, posterolateral fusion, and revision surgery and, in PLIF/TLIF, bleeding disorder predicted morbidity ( P < 0.001). Female sex ( P = 0.010), diabetes ( P = 0.042), COPD ( P = 0.011), and disseminated cancer ( P = 0.032) trended toward morbidity in PLIF/TLIF; obesity trended in PLIF/TLIF ( P = 0.0022) and ALIF/LLIF ( P = 0.020). Conclusion: PLIF/TLIF was associated with a 15.5% increased odds of morbidity; readmission and reoperation were similar between approaches. Older age, higher ASA-class, and specific comorbidities predicted poorer 30-day outcomes, while procedural-related factors predicted only morbidity. These findings can guide surgical approach given specific factors. Level of Evidence: 3 Abstract : Supplemental Digital Content is available in the textWe compared 30-day readmission, reoperation, and morbidity rates between posterior lumbar interbody fusion/ transforaminal lumbar interbody fusion and anterior lumbar interbody fusion/lateral lumbar interbody fusion in 26, 336 patients. Posterior lumbar interbody fusion /transforaminal lumbar interbody fusion independently predicted greater morbidity on multivariate analysis (odds ratio: 1.155, P ≡ 0.0019). Posterior lumbar interbody fusion /transforaminal lumbar interbody fusion also had greater operative time (P ≡ 0.015), transfusion (P < 0.001), urinary tract infection (P ≡ 0.008), and stroke/CVA (P ≡ 0.026), but lower prolonged ventilation (P < 0.001) and DVT/thrombophlebitis (P ≡ 0.002) rates.